Literature DB >> 8151565

Reactive arthritis: incidence, triggering agents and clinical presentation.

T K Kvien1, A Glennås, K Melby, K Granfors, O Andrup, B Karstensen, J E Thoen.   

Abstract

OBJECTIVE: To study the incidence and presenting clinical and microbiological features in subgroups of reactive arthritides.
METHODS: In a defined community and during a 2-year period, we studied prospectively patients between 18 and 60 years with onset of suspected reactive arthritis, primarily seen by general practitioners.
RESULTS: Annual minimum incidence of Chlamydia induced arthritis (n = 25) was 4.6 and of arthritis triggered by enterobacteria (n = 27) 5.0/100,000 individuals between 18 and 60 years. Triggering infections were asymptomatic in 36 and 26%, respectively. Patients with self-limiting arthritis without identified triggering agents (n = 60, incidence 11.0/100,000) had a normal prevalence of HLA-B27 and a more heterogeneous pattern of arthritis.
CONCLUSION: Our epidemiological study confirms suggested high incidence rates of reactive arthritides. Reactive arthritides must be considered in early arthritis, even without symptoms of triggering infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151565

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  43 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 2.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  [Reactive arthritis: from pathogenesis to novel strategies].

Authors:  M Rihl; J G Kuipers
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

4.  Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection.

Authors:  Miroslav Harjacek; Jelena Ostojic; Oktavija Djakovic Rode
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

5.  Shigella induced reactive arthritis.

Authors:  J S Hill Gaston
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 6.  The molecular pathogenesis of Chlamydia-induced arthritis: where do we stand?

Authors:  Markus Rihl; Henning Zeidler
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

Review 7.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

8.  Persistent infection of Chlamydia in reactive arthritis.

Authors:  M Rihl; L Köhler; A Klos; H Zeidler
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

9.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Annual incidence of inflammatory joint diseases in a population based study in southern Sweden.

Authors:  M K Söderlin; O Börjesson; H Kautiainen; T Skogh; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.